| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 237,938 | 227,300 | 263,455 | 270,679 | | Cost of Revenue | 254,325 | 41,542 | 37,628 | 31,351 | | | Gross Profit | (16,387) | 185,758 | 225,827 | 239,328 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (103,589) | 96,821 | 116,663 | 90,946 | | Non Recurring |
-
|
-
| 1,732,486 | 950,799 | | Others | 91,692 | 84,435 | 114,256 | 127,335 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (4,490) | 4,502 | (1,737,578) | (929,752) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (172,497) | 16,006 | 181,922 | 189,000 | | Earnings Before Interest And Taxes | (176,987) | 20,508 | (1,555,656) | (740,752) | | Interest Expense | (111,948) | 55,880 | 56,068 | 49,116 | | Income Before Tax | (65,039) | (35,372) | (1,611,724) | (789,868) | | Income Tax Expense | (24,862) | (13,368) | (611,971) | (244,729) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (40,177) | (22,004) | (999,753) | (545,139) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (40,177) | (22,004) | (999,753) | (545,139) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($40,177) | ($22,004) | ($999,753) | ($545,139) |
|
1.48% Nasdaq 
Income Statement
